0 281

Cited 0 times in

Cited 0 times in

Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study

DC Field Value Language
dc.date.accessioned2023-06-02T01:17:15Z-
dc.date.available2023-06-02T01:17:15Z-
dc.date.issued2022-11-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194789-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleTumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorM-J. Ahn-
dc.contributor.googleauthorB.C. Cho-
dc.contributor.googleauthorY.K. Pang-
dc.contributor.googleauthorP.J. Voon-
dc.contributor.googleauthorS-W. Kim-
dc.contributor.googleauthorJ. De Castro Carpeno-
dc.contributor.googleauthorM. Tiseo-
dc.contributor.googleauthorJ. Li-
dc.contributor.googleauthorL. Servidio-
dc.contributor.googleauthorS. Sadow-
dc.contributor.googleauthorA. Markovets-
dc.contributor.googleauthorK.H. Tang-
dc.contributor.googleauthorZ. Piotrowska-
dc.identifier.doi10.1016/j.annonc.2022.10.354-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422045458-
dc.citation.volume33-
dc.citation.numberSupplement 9-
dc.citation.startPageS1563-
dc.citation.endPageS1564-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Supplement 9) : S1563-S1564, 2022-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.